On the eve of a Philadelphia Risperdal trial, Johnson & Johnson and Janssen Pharmaceuticals Inc. agreed to settle a lawsuit alleging a New York boy grew female breasts after...
Last year, healthcare giant Johnson & Johnson (J&J) lost three multimillion-dollar baby powder cancer trials. Not eager to jump into the next trial, the company asked the Missouri Court...
Healthcare giant Johnson & Johnson (J&J) and its subsidiary, DePuy Orthopedics, were ordered to pay six plaintiffs over $1 billion last month due to injuries caused by the defective...
Healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals plan to ring in the new year with results from a seven year long study testing the effectiveness...
2016 has been a tough year healthcare giant Johnson & Johnson (J&J). The company lost several multimillion dollar baby powder cancer trials, lost a $70 million Risperdal trial, and...
Like many other women, Ann Christine Underwood regularly used Johnson & Johnson’s baby powder products for feminine hygiene. And, like thousands of other women, she developed ovarian cancer. Her...
The relationship between doctors and pharmaceutical companies has many restrictions. Pharmaceutical companies are not allowed to pay doctors kickbacks for prescribing certain medications. However, companies are allowed to pay...
It’s been a rough year for healthcare giant Johnson & Johnson (J&J). While the company is likely accustomed to fighting a high number of product liability lawsuits, 2016 saw...
The litigation against Ethicon Inc. and Johnson & Johnson (J&J) over their defective pelvic mesh products has been ongoing for years now, but the first case finally came to...
The sixth Risperdal case to go to trial in the Philadelphia mass tort program against manufacturers Janssen Pharmaceuticals and Johnson & Johnson (J&J) has come to an abrupt end...
